跳至主要内容
临床试验/NCT07241195
NCT07241195招募中不适用

Study on the Construction of Disease Cohort for Fatty Liver in the Elderly and Its Prevention and Treatment Strategies

The Affiliated Hospital of Hangzhou Normal University1 个研究点 分布在 1 个国家目标入组 20,000 人开始时间: 2026年3月12日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
20,000
试验地点
1
主要终点
Incidence of liver fibrosis

研究概览

简要总结

To establish a cohort of elderly fatty liver disease based on the community medical examination population. Through the large-scale cohort study, the risk factors affecting fatty liver in the elderly will be explored in depth from the aspects of lifestyle, environment and genetics, the development pattern and mechanism of fatty liver in the elderly will be analysed, and the health risk assessment system and Chinese standard for fatty liver in the elderly covering cardiovascular risk, risk of hepatic fibrosis and risk of sarcopenia will be established, so as to provide the scientific basis for the precise intervention of fatty liver in the elderly in China.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
65 Years 至 100 Years(Older Adult)
性别
All
接受健康志愿者
是

入选标准

  • •① Elderly people aged ≥65 years among permanent residents (living for more than 5 years) in the survey area;
  • •Imaging diagnosis (ultrasound or FibroScan/FibroTouch) of fatty liver; -③ Voluntary participation in this study and signing an informed consent form.

排除标准

  • •①Major disability, mental illness, major wasting disease, severe cardiac, pulmonary and renal insufficiency;
  • •Patients with combined primary liver cancer or other types of cancer; -③Patients who have received liver transplant or other organ transplants.

研究组 & 干预措施

control group

Observation Group

Lifestyle interventions

结局指标

主要结局

Incidence of liver fibrosis

时间窗: 2 years

次要结局

  • Incidence of cardiovascular disease(2 years)
  • Incidence of sarcopenia(2 years)

研究者

发起方
The Affiliated Hospital of Hangzhou Normal University
申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验